EG25498A - Method for producing (3-oxo-2.3-dihydro-1h-isoindol-1h-isoindol-1-yl)acetylguanidine derivatives - Google Patents

Method for producing (3-oxo-2.3-dihydro-1h-isoindol-1h-isoindol-1-yl)acetylguanidine derivatives

Info

Publication number
EG25498A
EG25498A EGNA2006000508A EG25498A EG 25498 A EG25498 A EG 25498A EG NA2006000508 A EGNA2006000508 A EG NA2006000508A EG 25498 A EG25498 A EG 25498A
Authority
EG
Egypt
Prior art keywords
isoindol
dihydro
oxo
producing
acetylguanidine
Prior art date
Application number
Inventor
Gerrit Schubert
Joerg Rieke-Zapp
Johannes Keil
Heinz-Werner Kleemann
Reda Hanna
Bao-Guo Huang
Xiao-Dong Wu
Yves Gouraud
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of EG25498A publication Critical patent/EG25498A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EGNA2006000508 2003-12-02 2006-06-01 Method for producing (3-oxo-2.3-dihydro-1h-isoindol-1h-isoindol-1-yl)acetylguanidine derivatives EG25498A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10356717A DE10356717A1 (en) 2003-12-02 2003-12-02 Process for the preparation of (3-oxo-2,3-dihydro-1H-isoindol-1-yl) -acetylguanidine derivatives
PCT/EP2004/013153 WO2005054195A1 (en) 2003-12-02 2004-11-19 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives

Publications (1)

Publication Number Publication Date
EG25498A true EG25498A (en) 2012-01-22

Family

ID=34638338

Family Applications (1)

Application Number Title Priority Date Filing Date
EGNA2006000508 EG25498A (en) 2003-12-02 2006-06-01 Method for producing (3-oxo-2.3-dihydro-1h-isoindol-1h-isoindol-1-yl)acetylguanidine derivatives

Country Status (38)

Country Link
EP (1) EP1692105B1 (en)
JP (1) JP4809774B2 (en)
KR (1) KR101202604B1 (en)
CN (1) CN100526297C (en)
AR (1) AR046733A1 (en)
AT (1) ATE395334T1 (en)
AU (1) AU2004295056B2 (en)
BR (1) BRPI0417147A (en)
CA (1) CA2548020C (en)
CR (1) CR8376A (en)
CY (1) CY1108187T1 (en)
DE (2) DE10356717A1 (en)
DK (1) DK1692105T3 (en)
EC (1) ECSP066597A (en)
EG (1) EG25498A (en)
ES (1) ES2304634T3 (en)
HK (1) HK1097525A1 (en)
HR (1) HRP20080253T3 (en)
IL (1) IL175834A (en)
JO (1) JO2498B1 (en)
MA (1) MA28220A1 (en)
MY (1) MY136467A (en)
NO (1) NO20063058L (en)
NZ (1) NZ547625A (en)
OA (1) OA13293A (en)
PA (1) PA8618701A1 (en)
PE (1) PE20051037A1 (en)
PL (1) PL1692105T3 (en)
PT (1) PT1692105E (en)
RS (1) RS50571B (en)
RU (1) RU2397159C2 (en)
SI (1) SI1692105T1 (en)
TN (1) TNSN06167A1 (en)
TW (1) TWI334348B (en)
UA (1) UA83883C2 (en)
UY (1) UY28648A1 (en)
WO (1) WO2005054195A1 (en)
ZA (1) ZA200603338B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
US8354382B2 (en) * 2008-04-16 2013-01-15 Kissei Pharmaceutical Co., Ltd. Hemifumarate of a pyrazole derivative
RU2518740C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE
CN107778238B (en) * 2016-08-29 2022-07-22 中山大学 Novel synthesis method of 3, 4-dihydroisoquinoline-1-ketone
CN107286074B (en) * 2017-08-16 2019-08-20 厦门华厦学院 3- hydroxyl iso-indoles -1- ketone derivatives and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
DE19737224A1 (en) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmaceutical preparation for cardiovascular treatment
DE19832429A1 (en) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction
WO2002081443A1 (en) 2001-04-09 2002-10-17 Chiron Corporation Novel guanidino compounds
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

Also Published As

Publication number Publication date
ZA200603338B (en) 2007-06-27
AU2004295056B2 (en) 2011-04-14
ECSP066597A (en) 2006-10-25
CN100526297C (en) 2009-08-12
DK1692105T3 (en) 2008-08-25
PE20051037A1 (en) 2005-12-29
MA28220A1 (en) 2006-10-02
EP1692105A1 (en) 2006-08-23
DE10356717A1 (en) 2005-07-07
IL175834A0 (en) 2006-10-05
CY1108187T1 (en) 2014-02-12
CA2548020C (en) 2013-01-08
RU2397159C2 (en) 2010-08-20
OA13293A (en) 2007-01-31
CN1886374A (en) 2006-12-27
DE502004007177D1 (en) 2008-06-26
MY136467A (en) 2008-10-31
TW200526207A (en) 2005-08-16
ES2304634T3 (en) 2008-10-16
CR8376A (en) 2007-12-04
NZ547625A (en) 2010-01-29
PA8618701A1 (en) 2006-07-03
TWI334348B (en) 2010-12-11
NO20063058L (en) 2006-06-30
SI1692105T1 (en) 2008-08-31
RU2006123410A (en) 2008-01-10
UY28648A1 (en) 2005-06-30
AR046733A1 (en) 2005-12-21
TNSN06167A1 (en) 2007-11-15
AU2004295056A1 (en) 2005-06-16
CA2548020A1 (en) 2005-06-16
KR20060111558A (en) 2006-10-27
JP2007516243A (en) 2007-06-21
HK1097525A1 (en) 2007-06-29
PL1692105T3 (en) 2008-09-30
IL175834A (en) 2010-12-30
BRPI0417147A (en) 2007-03-06
JO2498B1 (en) 2009-10-05
RS50571B (en) 2010-05-07
ATE395334T1 (en) 2008-05-15
PT1692105E (en) 2008-07-04
WO2005054195A1 (en) 2005-06-16
EP1692105B1 (en) 2008-05-14
UA83883C2 (en) 2008-08-26
HRP20080253T3 (en) 2008-09-30
KR101202604B1 (en) 2012-11-19
JP4809774B2 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
AU2003296732A1 (en) Method for producing polycarbonates
EP1484384A4 (en) Method for producing bio-fuel
PL1697390T3 (en) Method for producing organoacylphosphites
EP1437326A4 (en) METHOD FOR PRODUCING Si
EG25498A (en) Method for producing (3-oxo-2.3-dihydro-1h-isoindol-1h-isoindol-1-yl)acetylguanidine derivatives
PL1641731T3 (en) Method for producing 1-octene from crack-c4
EP1688422A4 (en) Method for producing organosilane
EP1612213A4 (en) Process for producing 2 -deoxy-2 -fluorouridine
AU2003206964A8 (en) Method for producing riboflavin
HK1133870A1 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
EP1701920A4 (en) Method for treating-containing solutions
EP1666474A4 (en) Method for producing propyleneoxide
EP1556396A4 (en) Method for producing 2-deoxy-l-ribose
AU2003257058A1 (en) Method for making alkyhalosilanes
HU0301605D0 (en) Method for producing hihg-purity citalopram
SG116494A1 (en) Process for producing w-mercaptoalkylpyridine.
AU2003223951A1 (en) Method for producing substituted oxazoles
SI1603868T1 (en) Method for producing alpha-(3-arylthio)-acetophenones
HU0300941D0 (en) Method for producing dialkyl-3-oxo-glutarates
PL359838A1 (en) Method for producing nano-pathes
SI1685097T1 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
AU2003291534A8 (en) Method for producing polyketides
AU2003249978A1 (en) Method for producing 1-methylcyclopropylguanidine
SI1480963T1 (en) Method for producing 3-amidinophenylalanine derivatives
EP1563057A4 (en) Method for producing riboflavin